
John D. Lee
Examiner (ID: 7564)
| Most Active Art Unit | 2501 |
| Art Unit(s) | 2501, 3621, 2874, 2606, 2504, 2507 |
| Total Applications | 2783 |
| Issued Applications | 2467 |
| Pending Applications | 118 |
| Abandoned Applications | 198 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7776445
[patent_doc_number] => 20120039944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'WHEY AND THYMUS FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 13/120118
[patent_app_country] => US
[patent_app_date] => 2009-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4302
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20120039944.pdf
[firstpage_image] =>[orig_patent_app_number] => 13120118
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/120118 | Whey and thymus function | Sep 13, 2009 | Issued |
Array
(
[id] => 6549620
[patent_doc_number] => 20100016562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'REDUCING THE IMMUNOGENICITY OF FUSION PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 12/552076
[patent_app_country] => US
[patent_app_date] => 2009-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15280
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20100016562.pdf
[firstpage_image] =>[orig_patent_app_number] => 12552076
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/552076 | Reducing the immunogenicity of fusion proteins | Aug 31, 2009 | Issued |
Array
(
[id] => 6574774
[patent_doc_number] => 20100129372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'INHIBITION OF PACAP SIGNALLING FOR THE PREVENTION AND TREATMENT OF THROMBOCYTOPENIA'
[patent_app_type] => utility
[patent_app_number] => 12/550605
[patent_app_country] => US
[patent_app_date] => 2009-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 11548
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20100129372.pdf
[firstpage_image] =>[orig_patent_app_number] => 12550605
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/550605 | INHIBITION OF PACAP SIGNALLING FOR THE PREVENTION AND TREATMENT OF THROMBOCYTOPENIA | Aug 30, 2009 | Abandoned |
Array
(
[id] => 6087949
[patent_doc_number] => 20110217317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'TREATMENT OF THROMBOCYTOPENIA'
[patent_app_type] => utility
[patent_app_number] => 13/061015
[patent_app_country] => US
[patent_app_date] => 2009-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 21285
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20110217317.pdf
[firstpage_image] =>[orig_patent_app_number] => 13061015
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/061015 | TREATMENT OF THROMBOCYTOPENIA | Aug 25, 2009 | Abandoned |
Array
(
[id] => 5958539
[patent_doc_number] => 20110182926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'MINIGENE'
[patent_app_type] => utility
[patent_app_number] => 13/058304
[patent_app_country] => US
[patent_app_date] => 2009-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 14167
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20110182926.pdf
[firstpage_image] =>[orig_patent_app_number] => 13058304
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/058304 | MINIGENE | Aug 6, 2009 | Abandoned |
Array
(
[id] => 6630867
[patent_doc_number] => 20100035270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'Methods and Compositions for the Detection of Bovine Pregnancy'
[patent_app_type] => utility
[patent_app_number] => 12/536189
[patent_app_country] => US
[patent_app_date] => 2009-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13284
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20100035270.pdf
[firstpage_image] =>[orig_patent_app_number] => 12536189
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/536189 | Methods and Compositions for the Detection of Bovine Pregnancy | Aug 4, 2009 | Abandoned |
Array
(
[id] => 8464648
[patent_doc_number] => 20120269817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor'
[patent_app_type] => utility
[patent_app_number] => 13/057728
[patent_app_country] => US
[patent_app_date] => 2009-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16884
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13057728
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/057728 | Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor | Aug 3, 2009 | Abandoned |
Array
(
[id] => 6347958
[patent_doc_number] => 20100330696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'Method of diagnosing endometriosis in human subjects'
[patent_app_type] => utility
[patent_app_number] => 12/460724
[patent_app_country] => US
[patent_app_date] => 2009-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 18111
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 44
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0330/20100330696.pdf
[firstpage_image] =>[orig_patent_app_number] => 12460724
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/460724 | Method of detecting endometriosis in human subjects using SEQ ID No. 9 or an epitope thereof | Jul 21, 2009 | Issued |
Array
(
[id] => 7487503
[patent_doc_number] => 20110236405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'COAGULATION FACTOR MODULATION FOR CONTROLLING TRANSPLANT ORGAN SIZE'
[patent_app_type] => utility
[patent_app_number] => 13/056665
[patent_app_country] => US
[patent_app_date] => 2009-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 21240
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20110236405.pdf
[firstpage_image] =>[orig_patent_app_number] => 13056665
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/056665 | COAGULATION FACTOR MODULATION FOR CONTROLLING TRANSPLANT ORGAN SIZE | Jul 18, 2009 | Abandoned |
Array
(
[id] => 4550326
[patent_doc_number] => 07960532
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-14
[patent_title] => 'Polynucleotides encoding anticoagulant antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/503893
[patent_app_country] => US
[patent_app_date] => 2009-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15513
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/960/07960532.pdf
[firstpage_image] =>[orig_patent_app_number] => 12503893
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/503893 | Polynucleotides encoding anticoagulant antibodies | Jul 15, 2009 | Issued |
Array
(
[id] => 6595156
[patent_doc_number] => 20100062453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'Method of diagnosing endometriosis in human subjects'
[patent_app_type] => utility
[patent_app_number] => 12/460255
[patent_app_country] => US
[patent_app_date] => 2009-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 18142
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 44
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20100062453.pdf
[firstpage_image] =>[orig_patent_app_number] => 12460255
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/460255 | Methods of diagnosing endometriosis in human subjects using the ME-5 polypeptide | Jul 14, 2009 | Issued |
Array
(
[id] => 6616498
[patent_doc_number] => 20100003248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'POLYPEPTIDE CONSTRUCTS FOR RECTAL AND/OR VAGINAL ADMINISTRATION'
[patent_app_type] => utility
[patent_app_number] => 12/487712
[patent_app_country] => US
[patent_app_date] => 2009-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 34839
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20100003248.pdf
[firstpage_image] =>[orig_patent_app_number] => 12487712
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/487712 | POLYPEPTIDE CONSTRUCTS FOR RECTAL AND/OR VAGINAL ADMINISTRATION | Jun 18, 2009 | Abandoned |
Array
(
[id] => 5464312
[patent_doc_number] => 20090324512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'POLYPEPTIDE CONSTRUCTS FOR NASAL ADMINISTRATION'
[patent_app_type] => utility
[patent_app_number] => 12/487949
[patent_app_country] => US
[patent_app_date] => 2009-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 34853
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20090324512.pdf
[firstpage_image] =>[orig_patent_app_number] => 12487949
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/487949 | POLYPEPTIDE CONSTRUCTS FOR NASAL ADMINISTRATION | Jun 18, 2009 | Abandoned |
Array
(
[id] => 6348500
[patent_doc_number] => 20100021459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'POLYPEPTIDE CONSTRUCTS FOR INTRACELLULAR DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 12/487684
[patent_app_country] => US
[patent_app_date] => 2009-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 34753
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20100021459.pdf
[firstpage_image] =>[orig_patent_app_number] => 12487684
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/487684 | Polypeptide constructs including VHH directed against EGFR for intracellular delivery | Jun 18, 2009 | Issued |
Array
(
[id] => 6467305
[patent_doc_number] => 20100040613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'POLYPEPTIDE CONSTRUCTS FOR SUBLINGUAL ADMINISTRATION'
[patent_app_type] => utility
[patent_app_number] => 12/488077
[patent_app_country] => US
[patent_app_date] => 2009-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 34857
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20100040613.pdf
[firstpage_image] =>[orig_patent_app_number] => 12488077
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/488077 | POLYPEPTIDE CONSTRUCTS FOR SUBLINGUAL ADMINISTRATION | Jun 18, 2009 | Abandoned |
Array
(
[id] => 6159617
[patent_doc_number] => 20110159006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'USE OF ANTI-FACTOR XI ANTIBODIES FOR PREVENTION OF THROMBUS FORMATION'
[patent_app_type] => utility
[patent_app_number] => 13/000284
[patent_app_country] => US
[patent_app_date] => 2009-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14874
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20110159006.pdf
[firstpage_image] =>[orig_patent_app_number] => 13000284
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/000284 | USE OF ANTI-FACTOR XI ANTIBODIES FOR PREVENTION OF THROMBUS FORMATION | Jun 18, 2009 | Abandoned |
Array
(
[id] => 6616533
[patent_doc_number] => 20100003249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'POLYPEPTIDE CONSTRUCTS FOR TOPICAL ADMINISTRATION'
[patent_app_type] => utility
[patent_app_number] => 12/487895
[patent_app_country] => US
[patent_app_date] => 2009-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 34847
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20100003249.pdf
[firstpage_image] =>[orig_patent_app_number] => 12487895
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/487895 | POLYPEPTIDE CONSTRUCTS FOR TOPICAL ADMINISTRATION | Jun 18, 2009 | Abandoned |
Array
(
[id] => 5943525
[patent_doc_number] => 20110104145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'METHOD FOR THE TREATMENT OR PROPHYLAXIS OF CHRONIC INFLAMMATORY DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/736963
[patent_app_country] => US
[patent_app_date] => 2009-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11466
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20110104145.pdf
[firstpage_image] =>[orig_patent_app_number] => 12736963
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/736963 | METHOD FOR THE TREATMENT OR PROPHYLAXIS OF CHRONIC INFLAMMATORY DISEASES | May 27, 2009 | Abandoned |
Array
(
[id] => 6212281
[patent_doc_number] => 20110135581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'Methods and Compositions for Reducing Lung Inflammation in an Animal'
[patent_app_type] => utility
[patent_app_number] => 12/992913
[patent_app_country] => US
[patent_app_date] => 2009-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 5143
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20110135581.pdf
[firstpage_image] =>[orig_patent_app_number] => 12992913
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/992913 | Methods and compositions containing at least 30% IgG and 10% or less by weight IgA for reducing lung inflammation in an animal | May 21, 2009 | Issued |
Array
(
[id] => 6055921
[patent_doc_number] => 20110112281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'CYTOTOXIC COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/993684
[patent_app_country] => US
[patent_app_date] => 2009-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6584
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20110112281.pdf
[firstpage_image] =>[orig_patent_app_number] => 12993684
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/993684 | CYTOTOXIC COMPOSITION | May 18, 2009 | Abandoned |